Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including those that presented with unconventional symptoms, or atypical ECG patterns ...
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances ...
Hosted on MSN
AI ECG better detects severe heart attacks in emergency setting, and have fewer false positives
Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including those that presented with unconventional symptoms, or atypical ECG patterns ...
Collaboration Expands Reach of MaxYield into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ACCESS Newswire / March 31, 2026 / AI/ML Innovations Inc. ("AIML" or the "Comp ...
Commercial integration expands MaxYield™ and CardioYield™ into V-PRO and S-PRO clinical and performance product lines TORONTO, ON / ACCESS Newswire / November 26, 2025 / NeuralCloud Solutions Inc.
Atrial fibrillation (AF) represents a complex disorder of cardiac rhythm, deeply rooted in the intricate interplay between molecular, cellular, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results